ωconotoxin peptides

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S002600, C530S325000, C530S300000, C435S007200

Reexamination Certificate

active

07101849

ABSTRACT:
An isolated, synthetic, or recombinant ω-conotoxin peptide in which the fourth loop between cysteine residues 5 and 6 comprises SEQ ID NO: 1 or such a sequence which has undergone one or more amino acid substitutions or side chain modifications, and uses therefor. SEQ ID NO: 1 comprises the amino acid sequence SGTVGR.

REFERENCES:
patent: 5364842 (1994-11-01), Justice et al.
patent: 5424218 (1995-06-01), Miljanich et al.
K.J. Nielsen et al., (1996) “A Consensus Structure for ω-Conotoxins with Different Selectivities for Voltage-sensitive Calcium Channel Subtypes: Comparison of MVIIA, SVIB and SNX-202”, (Journal of Molecular Biology, vol. 263, pp. 297-310.
K. Sato et al. (1997), “Binding of Chimeric Analogs of ω-Conotoxin MVIIA and MVIIC to the N-and P70-type Calcium Channels”, (FEBS Letters, vol. 414, pp., 480-484.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

ωconotoxin peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with ωconotoxin peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and ωconotoxin peptides will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3559761

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.